- Home
- SGMT vs OSUR Comparison
SGMT vs OSUR Comparison
Compare SGMT & OSUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGMT
- OSUR
- Stock Information
- Founded
- SGMT 2006
- OSUR 2000
- Country
- SGMT United States
- OSUR United States
- Employees
- SGMT N/A
- OSUR N/A
- Industry
- SGMT
- OSUR Medical/Dental Instruments
- Sector
- SGMT
- OSUR Health Care
- Exchange
- SGMT Nasdaq
- OSUR Nasdaq
- Market Cap
- SGMT 238.7M
- OSUR 229.7M
- IPO Year
- SGMT 2023
- OSUR 1986
- Fundamental
- Price
- SGMT $7.31
- OSUR $3.24
- Analyst Decision
- SGMT Strong Buy
- OSUR Hold
- Analyst Count
- SGMT 7
- OSUR 1
- Target Price
- SGMT $26.57
- OSUR $3.00
- AVG Volume (30 Days)
- SGMT 480.3K
- OSUR 501.5K
- Earning Date
- SGMT 11-12-2025
- OSUR 11-05-2025
- Dividend Yield
- SGMT N/A
- OSUR N/A
- EPS Growth
- SGMT N/A
- OSUR N/A
- EPS
- SGMT N/A
- OSUR N/A
- Revenue
- SGMT N/A
- OSUR $138,533,000.00
- Revenue This Year
- SGMT N/A
- OSUR N/A
- Revenue Next Year
- SGMT N/A
- OSUR $4.32
- P/E Ratio
- SGMT N/A
- OSUR N/A
- Revenue Growth
- SGMT N/A
- OSUR N/A
- 52 Week Low
- SGMT $1.73
- OSUR $2.36
- 52 Week High
- SGMT $11.41
- OSUR $4.60
- Technical
- Relative Strength Index (RSI)
- SGMT 52.06
- OSUR 48.29
- Support Level
- SGMT $7.11
- OSUR $3.10
- Resistance Level
- SGMT $7.66
- OSUR $3.25
- Average True Range (ATR)
- SGMT 0.40
- OSUR 0.10
- MACD
- SGMT 0.11
- OSUR -0.02
- Stochastic Oscillator
- SGMT 76.45
- OSUR 18.75
About SGMT Sagimet Biosciences Inc. Series A
Sagimet Biosciences Inc is a clinical-stage biopharmaceutical company dedicated to developing a portfolio of in-house discovered, selective fatty acid synthase (FASN) inhibitors aimed at treating diseases that arise from dysfunctional lipid metabolism pathways. The company's drug candidate, denifanstat, is an oral, once-daily pill that serves as a selective FASN inhibitor under development for treating nonalcoholic steatohepatitis (NASH). The company functions as a single business segment, focusing on the development and commercialization of therapeutics for MASH and other diseases where FASN plays a pathogenic role.
About OSUR OraSure Technologies Inc.
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.